From continuous glucose monitoring to GLP-1 therapies — the science of metabolic optimization for high-performance living
"Metabolic dysfunction is the silent driver behind nearly every chronic disease. Fix the metabolism, and you change the trajectory of a life."— Dr. Marcus Hale, Chief Medical Contributor
of UHNW individuals now use CGM devices
GLP-1 market projected by 2030
greater longevity risk from metabolic syndrome vs. smoking
Eli Lilly's Zepbound and Novo Nordisk's Ozempic have done more than reshape bodies — they've reshaped an entire industry. We examine the science, the investment thesis, and what comes next for the $100 billion GLP-1 market.
Once reserved for diabetics, CGM devices are now the cornerstone of elite performance optimization — and the data is transforming how physicians think about metabolic health.
HOMA-IR, fasting insulin, and the metabolic markers that predict cardiovascular risk, cognitive decline, and longevity — years before conventional labs flag a problem.
A rigorous look at the evidence behind 16:8, 18:6, and extended fasting protocols — separating the peer-reviewed science from the wellness industry hype.
"The CGM is the most democratizing technology in preventive medicine since the blood pressure cuff. It gives you real-time feedback on every meal, every workout, every night of sleep."